Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group. [electronic resource]
Producer: 19950222Description: 362-9 p. digitalISSN:- 0735-1097
- Angioplasty, Balloon, Coronary
- Aspirin -- therapeutic use
- Cilazapril -- administration & dosage
- Coronary Angiography
- Coronary Disease -- diagnostic imaging
- Double-Blind Method
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Linear Models
- Male
- Middle Aged
- Recurrence
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.